Clinical trials in sepsis: An update

Current Opinion in Anaesthesiology

Volumn 13, Issue 2, 2000, Pages 125-129

  Sevransky, Jonathan ^a   Natanson, Charles ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRADYKININ ANTAGONIST; CORTICOSTEROID; GLUCOCORTICOID; HYDROCORTISONE; IBUPROFEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; PROSTAGLANDIN; RECEPTOR BLOCKING AGENT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG MEGADOSE; HUMAN; MEDIATOR; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0034075829     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200004000-00007     Document Type: Article

References (8)